This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n5http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07766/identifier/pdb/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07766/identifier/pubchem-compound/
n6http://linked.opendata.cz/resource/drugbank/property/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07766/identifier/pubchem-substance/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB07766/identifier/drugbank/

Statements

Subject Item
n2:DB07766
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n5:DB07766 n10:DB07766
dcterms:title
(2Z,3E)-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-{O-[(3R)-3,4-DIHYDROXYBUTYL]OXIME}
adms:identifier
n8:24880018 n9:99444237 n11:DB07766 n12:FEF
n3:IUPAC-Name
n6:271B6447-363D-11E5-9242-09173F13E4C5
n3:InChI
n6:271B644D-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n6:271B644C-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n6:271B6449-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n6:271B644A-363D-11E5-9242-09173F13E4C5
n3:SMILES
n6:271B644B-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n6:271B6445-363D-11E5-9242-09173F13E4C5
n3:logP
n6:271B6443-363D-11E5-9242-09173F13E4C5 n6:271B6446-363D-11E5-9242-09173F13E4C5
n3:logS
n6:271B6444-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n6:271B6453-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n6:271B6454-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n6:271B644E-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n6:271B644F-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n6:271B6451-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n6:271B6450-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n6:271B6452-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n6:271B6459-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n6:271B645B-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n6:271B645C-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n6:271B6458-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n6:271B6457-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n6:271B645A-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n6:271B6448-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n6:271B6455-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n6:271B6456-363D-11E5-9242-09173F13E4C5